321734-92-3

Upstream product

• 21193-75-9 D-galactal 
• 124751-19-5 (2R,3R,4R)-2-(((tert-butyldimethylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diol 
• 3866-62-4 2,3,4,6-tetrakis-O-(phenylmethyl)-1-O-acetyl-α-D-galactopyranose 
• 53008-62-1 2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl iodide 
• 130323-37-4 (2R,3R,4R)-(3,4-bis(benzyloxy)-3,4-dihydro-2H-pyran-2-yl)methanol 
• 112289-35-7 3,4,6-tri-O-benzyl-β-D-galactopyranosyl fluoride 
• 112289-38-0 1,2-anhydro-3,4,6-tri-O-benzyl-D-galactopyranose 
• 80040-79-5 3,4,6-tri-O-benzyl-D-galactal 
• 101966-50-1 2,3,4,6-tetrakis-O-(phenylmethyl)-β-D-galactopyranosyl fluoride 

Relevant academic research and scientific papers

Synthesis and biological evaluation of α-galactosylceramide analogues with heteroaromatic rings and varying positions of a phenyl group in the sphingosine backbone

We designed and synthesized seven α-GalCer analogues with a pyrazole moiety and varying positions of a phenyl group in the sphingosine backbone to polarize cytokine secretion. On the basis of in vitro and in vivo biological evaluations, we found that anal

2-Deoxy-disaccharide approach to natural and unnatural glycosphingolipids synthesis

2-Deoxy-disaccharides were easily converted into glycosylphytosphingosines, as new and efficient precursors of natural and unnatural glycosphingolipids. Copyright (C) 2000 Elsevier Science Ltd.